Curcumin Activates the Nrf2 Pathway and Induces Cellular Protection Against Oxidative Injury.


Journal

Current molecular medicine
ISSN: 1875-5666
Titre abrégé: Curr Mol Med
Pays: Netherlands
ID NLM: 101093076

Informations de publication

Date de publication:
2020
Historique:
received: 30 07 2019
revised: 11 09 2019
accepted: 18 09 2019
pubmed: 18 10 2019
medline: 11 6 2021
entrez: 18 10 2019
Statut: ppublish

Résumé

Curcumin is a naturally occurring polyphenol that is isolated from the rhizome of Curcuma longa (turmeric). This medicinal compound has different biological activities, including antioxidant, antibacterial, antineoplastic, and anti-inflammatory. It also has therapeutic effects on neurodegenerative disorders, renal disorders, and diabetes mellitus. Curcumin is safe and well-tolerated at high concentrations without inducing toxicity. It seems that curcumin is capable of targeting the Nrf2 signaling pathway in protecting the cells against oxidative damage. Besides, this strategy is advantageous in cancer therapy. Accumulating data demonstrates that curcumin applies four distinct ways to stimulate the Nrf2 signaling pathway, including inhibition of Keap1, affecting the upstream mediators of Nrf2, influencing the expression of Nrf2 and target genes, and finally, improving the nuclear translocation of Nrf2. In the present review, the effects of curcumin on the Nrf2 signaling pathway to exert its therapeutic and biological activities has been discussed.

Identifiants

pubmed: 31622191
pii: CMM-EPUB-101541
doi: 10.2174/1566524019666191016150757
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antineoplastic Agents, Phytogenic 0
Antioxidants 0
Cardiotonic Agents 0
Hypoglycemic Agents 0
KEAP1 protein, human 0
Kelch-Like ECH-Associated Protein 1 0
NF-E2-Related Factor 2 0
NFE2L2 protein, human 0
Neuroprotective Agents 0
Nfe2l2 protein, mouse 0
Radiation-Protective Agents 0
Curcumin IT942ZTH98

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

116-133

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Milad Ashrafizadeh (M)

Department of Basic Science, Faculty of Veterinary Medicine, University of Tabriz, Tabriz, Iran.

Zahra Ahmadi (Z)

Department of Basic Science, Veterinary Medicine Faculty, Shushtar University, Khuzestan, Iran.

Reza Mohammadinejad (R)

Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Tahereh Farkhondeh (T)

Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Saeed Samarghandian (S)

Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH